| Valerie Van Ravenswaay, DO | |
|
1200 N Beaver St, Flagstaff, AZ 86001 | |
| (928) 214-2920 | |
| (928) 214-2925 |
| Full Name | Valerie Van Ravenswaay |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 6 Years |
| Location | 1200 N Beaver St, Flagstaff, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376930669 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 0007591 (Arizona) | Secondary |
| 208M00000X | Hospitalist | 0007591 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Flagstaff Medical Center | Flagstaff, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northern Arizona Healthcare Corporation | 3577473362 | 370 |
News Archive
Palomar Medical Technologies, Inc., a leading researcher and developer of light-based systems for aesthetic treatments, is pleased to announce that the MaxG™ Optimized Pulsed Light™ (OPL) handpiece is now available worldwide for use on the company's StarLux® 500 and Artisan™ laser and pulsed light aesthetic systems.
Amedisys, Inc., one of America's leading home health nursing companies, today reported its financial results for the three months and year ended December 31, 2009. We posted record financial performance with net service revenue and net income attributable to Amedisys, Inc., increasing 19.2% and 43.5%, respectively, over the three month period ended December 31, 2008.
The U.S. Food and Drug Administration today announced, in accordance with longstanding U.S. obligations under the Montreal Protocol on Substances that Deplete the Ozone Layer, seven metered-dose inhalers (MDI) used to treat asthma and chronic obstructive pulmonary disease (COPD) will be gradually removed from the U.S. marketplace. These inhalers contain ozone-depleting chlorofluorocarbons (CFCs), which are propellants that move medication out of the inhaler and into the lungs of patients.
The objective of genetic medicine is to analyze all the genes that make up the human genome, in order to identify as many genetic diseases as possible. Indeed, each gene variation has the potential to trigger specific defects. Among all genetic conditions, diseases known as "recessive" occur only when both the father and the mother are healthy carriers of the same defective gene which can be passed down to their children.
› Verified 8 days ago
| Entity Name | Northern Arizona Healthcare Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669914552 PECOS PAC ID: 3577473362 Enrollment ID: O20170801003409 |
News Archive
Palomar Medical Technologies, Inc., a leading researcher and developer of light-based systems for aesthetic treatments, is pleased to announce that the MaxG™ Optimized Pulsed Light™ (OPL) handpiece is now available worldwide for use on the company's StarLux® 500 and Artisan™ laser and pulsed light aesthetic systems.
Amedisys, Inc., one of America's leading home health nursing companies, today reported its financial results for the three months and year ended December 31, 2009. We posted record financial performance with net service revenue and net income attributable to Amedisys, Inc., increasing 19.2% and 43.5%, respectively, over the three month period ended December 31, 2008.
The U.S. Food and Drug Administration today announced, in accordance with longstanding U.S. obligations under the Montreal Protocol on Substances that Deplete the Ozone Layer, seven metered-dose inhalers (MDI) used to treat asthma and chronic obstructive pulmonary disease (COPD) will be gradually removed from the U.S. marketplace. These inhalers contain ozone-depleting chlorofluorocarbons (CFCs), which are propellants that move medication out of the inhaler and into the lungs of patients.
The objective of genetic medicine is to analyze all the genes that make up the human genome, in order to identify as many genetic diseases as possible. Indeed, each gene variation has the potential to trigger specific defects. Among all genetic conditions, diseases known as "recessive" occur only when both the father and the mother are healthy carriers of the same defective gene which can be passed down to their children.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Valerie Van Ravenswaay, DO 1200 N Beaver St, Flagstaff, AZ 86001-3118 Ph: (928) 213-6235 | Valerie Van Ravenswaay, DO 1200 N Beaver St, Flagstaff, AZ 86001 Ph: (928) 214-2920 |
News Archive
Palomar Medical Technologies, Inc., a leading researcher and developer of light-based systems for aesthetic treatments, is pleased to announce that the MaxG™ Optimized Pulsed Light™ (OPL) handpiece is now available worldwide for use on the company's StarLux® 500 and Artisan™ laser and pulsed light aesthetic systems.
Amedisys, Inc., one of America's leading home health nursing companies, today reported its financial results for the three months and year ended December 31, 2009. We posted record financial performance with net service revenue and net income attributable to Amedisys, Inc., increasing 19.2% and 43.5%, respectively, over the three month period ended December 31, 2008.
The U.S. Food and Drug Administration today announced, in accordance with longstanding U.S. obligations under the Montreal Protocol on Substances that Deplete the Ozone Layer, seven metered-dose inhalers (MDI) used to treat asthma and chronic obstructive pulmonary disease (COPD) will be gradually removed from the U.S. marketplace. These inhalers contain ozone-depleting chlorofluorocarbons (CFCs), which are propellants that move medication out of the inhaler and into the lungs of patients.
The objective of genetic medicine is to analyze all the genes that make up the human genome, in order to identify as many genetic diseases as possible. Indeed, each gene variation has the potential to trigger specific defects. Among all genetic conditions, diseases known as "recessive" occur only when both the father and the mother are healthy carriers of the same defective gene which can be passed down to their children.
› Verified 8 days ago
Dr. Sanya Aysha Kayani, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1200 N Beaver St, Flagstaff, AZ 86001 Phone: 928-214-2920 Fax: 928-214-2925 | |
Brandon Robert Thomas, DO Hospitalist Medicare: Medicare Enrolled Practice Location: 1200 N Beaver St, Flagstaff, AZ 86001 Phone: 928-779-3366 | |
Dr. Christine Marie Kneisel, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1200 N Beaver St, Flagstaff, AZ 86001 Phone: 928-214-2920 Fax: 928-214-2925 | |
Edward G Paul, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2920 N 4th St, Flagstaff, AZ 86004 Phone: 928-522-9400 Fax: 928-774-4808 | |
Dr. Marian Lacy, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1200 N Beaver St, Flagstaff, AZ 86001 Phone: 928-213-6235 Fax: 928-213-6292 | |
Audrey Lee, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1200 N Beaver St, Flagstaff, AZ 86001 Phone: 928-214-2920 Fax: 928-214-2925 | |
Dr. Matthew Randolph, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1200 N Beaver St, Flagstaff, AZ 86001 Phone: 928-214-2920 |